Journal of UrologyPub Date : 2025-06-01Epub Date: 2025-02-05DOI: 10.1097/JU.0000000000004446
Jin Kyu Kim, Mandy Rickard, Armando Lorenzo
{"title":"Letter: Artificial Intelligence as a Discriminator of Competence in Urological Training: Are We There?","authors":"Jin Kyu Kim, Mandy Rickard, Armando Lorenzo","doi":"10.1097/JU.0000000000004446","DOIUrl":"10.1097/JU.0000000000004446","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"795-796"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143189574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of UrologyPub Date : 2025-06-01Epub Date: 2025-03-05DOI: 10.1097/JU.0000000000004485
María Paula Herrera-Peña, Juan Carlos Velez-Roman
{"title":"Letter: Time to Change Our Mindset! Integrating Sustainability Into Urological Practice.","authors":"María Paula Herrera-Peña, Juan Carlos Velez-Roman","doi":"10.1097/JU.0000000000004485","DOIUrl":"10.1097/JU.0000000000004485","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"793"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143557219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of UrologyPub Date : 2025-06-01Epub Date: 2025-05-09DOI: 10.1097/JU.0000000000004557
{"title":"<i>The Journal of Urology</i><sup>®</sup> Home Study Course 2025 Volume 213/214.","authors":"","doi":"10.1097/JU.0000000000004557","DOIUrl":"https://doi.org/10.1097/JU.0000000000004557","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":"213 6","pages":"820-821"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144031986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of UrologyPub Date : 2025-06-01Epub Date: 2025-03-25DOI: 10.1097/JU.0000000000004523
Jiping Zeng, Jacob McFadden, Parth Thakker, Isamu Tachibana, Timothy A Masterson, Clint Cary
{"title":"Reply by Authors.","authors":"Jiping Zeng, Jacob McFadden, Parth Thakker, Isamu Tachibana, Timothy A Masterson, Clint Cary","doi":"10.1097/JU.0000000000004523","DOIUrl":"10.1097/JU.0000000000004523","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"765"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143700808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of UrologyPub Date : 2025-06-01Epub Date: 2025-02-10DOI: 10.1097/JU.0000000000004454
David E Hinojosa-Gonzalez
{"title":"Letter: Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis.","authors":"David E Hinojosa-Gonzalez","doi":"10.1097/JU.0000000000004454","DOIUrl":"10.1097/JU.0000000000004454","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"794-795"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143382771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Journal of UrologyPub Date : 2025-06-01Epub Date: 2025-05-09DOI: 10.1097/JU.0000000000004505
David S Wang
{"title":"Office Urology, Perioperative Care, Urinary Diversions.","authors":"David S Wang","doi":"10.1097/JU.0000000000004505","DOIUrl":"https://doi.org/10.1097/JU.0000000000004505","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":"213 6","pages":"815"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial Carcinoma.","authors":"Jiwei Huang, Xingyun Cai, Cheoklong Ng, Yuansheng Luo, Qiong Chen, Zaoyu Wang, Keying Qiao, Wen Kong, Jin Zhang, Yonghui Chen, Wei Zhang, Jiyang Zhang, Dadong Zhang, Guangyu Wu, Haige Chen, Wei Xue","doi":"10.1097/JU.0000000000004475","DOIUrl":"10.1097/JU.0000000000004475","url":null,"abstract":"<p><strong>Purpose: </strong>We investigated the efficacy and safety of tislelizumab as neoadjuvant therapy in patients with cisplatin-ineligible high-risk upper tract urothelial carcinoma (UTUC).</p><p><strong>Materials and methods: </strong>In this single-arm phase 2 trial (NCT04672330), 20 patients with high-risk UTUC were enrolled. Eligibility criteria included high-risk UTUC (defined as high-grade UTUC confirmed by endoscopic biopsy or urinary cytology, radiographic evidence of invasion [cT2-T4N0-2M0], and/or hydronephrosis), an Eastern Cooperative Oncology Group performance status of 0 to 2, no previous systemic therapy, and cisplatin ineligibility. Patients received neoadjuvant tislelizumab before radical surgery. Contrast-enhanced MRI was performed before the third dose and again before surgery. The primary end point was pathological complete response rate (ypT0N0). Secondary end points included pathological response rate (≤ypT1N0), objective response rate, disease-free survival, safety profile, and perioperative complications. Multiplex immunofluorescence assessed immune cell populations in the tumor microenvironment.</p><p><strong>Results: </strong>Among the 20 patients, 13 underwent radical nephroureterectomy, 1 received endoscopic ablation, and 3 had segmental ureteral resection. Three patients declined surgery because of disease progression or adverse events. The pathological complete response rate was 20%, with 45% of patients restaged to ≤ pT1. Median disease-free survival and overall survival were not reached. Grade 3/4 treatment-related adverse event occurred in 15% of patients. MRI analysis revealed higher apparent diffusion coefficient entropy in patients with partial response. Exploratory analysis showed increased PD-L1<sup>+</sup>CD68<sup>+</sup> macrophages and PD-1<sup>+</sup>CD8<sup>+</sup> T cells in the tumor stroma of partial and complete responders.</p><p><strong>Conclusions: </strong>Neoadjuvant tislelizumab showed promising efficacy and manageable toxicity in patients with high-risk, cisplatin-ineligible UTUC. Increased apparent diffusion coefficient entropy on MRI and the presence of PD-L1<sup>+</sup>CD68<sup>+</sup> macrophages in the tumor stroma may serve as potential predictors of response to neoadjuvant tislelizumab.</p><p><strong>Trial registration no.: </strong>NCT04672330.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"739-752"},"PeriodicalIF":5.9,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143501841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}